Following the lead of its advisers, the US Food and Drug Administration (FDA) today granted emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine for children 5 to 11 years old.The step moves vaccination of that age-group a step closer to becoming a reality.
The Advisory Committee on Immunization Practices (ACIP), which reports to the Centers for Disease Control and Prevention (CDC), will take up the matter on Nov 2.
The CDC typically follows ACIP advice, and once it clears the vaccine, it will roll out to younger kids across the country.States are preparing to receive hundreds of thousands of doses of the lower-dose Pfizer vaccine for young children as early as next week.Three days ago, the 19-member Vaccines and